99 related articles for article (PubMed ID: 32322742)
21. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial.
Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM;
J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506
[TBL] [Abstract][Full Text] [Related]
22. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
23. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial.
Mir F; Nisar I; Tikmani SS; Baloch B; Shakoor S; Jehan F; Ahmed I; Cousens S; Zaidi AK
Lancet Glob Health; 2017 Feb; 5(2):e177-e185. PubMed ID: 27988146
[TBL] [Abstract][Full Text] [Related]
24. [Acceptability, compliance and schedule of administration of oral antibiotics in outpatient children].
Wollner A; Lécuyer A; De La Rocque F; Sedletzki G; Derkx V; Boucherat M; Elbez A; Gelbert-Baudino N; Levy C; Corrard F; Cohen R
Arch Pediatr; 2011 May; 18(5):611-6. PubMed ID: 21420838
[TBL] [Abstract][Full Text] [Related]
25. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.
Greenberg D; Givon-Lavi N; Sadaka Y; Ben-Shimol S; Bar-Ziv J; Dagan R
Pediatr Infect Dis J; 2014 Feb; 33(2):136-42. PubMed ID: 23989106
[TBL] [Abstract][Full Text] [Related]
26. Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey.
Nsabagasani X; Ogwal-Okeng J; Mbonye A; Ssengooba F; Muhumuza S; Hansen EH
J Pharm Policy Pract; 2015; 8(1):18. PubMed ID: 25995847
[TBL] [Abstract][Full Text] [Related]
27. Penicillin V versus amoxicillin for pneumonia in children - a Swedish nationwide emulated target trial.
Rhedin S; Kvist B; Osvald EC; Karte G; Smew AI; Nauclér P; Lundholm C; Almqvist C
Clin Microbiol Infect; 2024 Jun; ():. PubMed ID: 38889864
[TBL] [Abstract][Full Text] [Related]
28. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
Lodha R; Randev S; Kabra SK
Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
[TBL] [Abstract][Full Text] [Related]
29. Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.
Nebot Giralt A; Nöstlinger C; Lee J; Salami O; Lallemant M; Ouma O; Nyamongo I; Marchal B
BMJ Open; 2017 Mar; 7(3):e014528. PubMed ID: 28360249
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
[TBL] [Abstract][Full Text] [Related]
31. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
[TBL] [Abstract][Full Text] [Related]
32. Universal versus conditional day 3 follow-up for children with non-severe unclassified fever at the community level in the Democratic Republic of the Congo: A cluster-randomized, community-based non-inferiority trial.
Mullany LC; van Boetzelaer EW; Gutman JR; Steinhardt LC; Ngoy P; Barbera Lainez Y; Wittcoff A; Harvey SA; Ho LS
PLoS Med; 2018 Apr; 15(4):e1002552. PubMed ID: 29664951
[TBL] [Abstract][Full Text] [Related]
33. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S
Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Fisher CL; Busman T; Olson CA
Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
36. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
[TBL] [Abstract][Full Text] [Related]
37. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial.
Awasthi S; Agarwal G; Singh JV; Kabra SK; Pillai RM; Singhi S; Nongkynrih B; Dwivedi R; More VB; Kulkarni M; Niswade AK; Bharti B; Ambast A; Dhasmana P;
J Trop Pediatr; 2008 Dec; 54(6):382-9. PubMed ID: 18611959
[TBL] [Abstract][Full Text] [Related]
39. Comparable outcomes among trial and nontrial participants in a clinical trial of antibiotics for childhood pneumonia: a retrospective cohort study.
Agweyu A; Oliwa J; Gathara D; Muinga N; Allen E; Lilford RJ; English M
J Clin Epidemiol; 2018 Feb; 94():1-7. PubMed ID: 29097339
[TBL] [Abstract][Full Text] [Related]
40. High Acceptability of an Orally Dispersible Tablet Formulation by Children.
Wagner-Hattler L; Kiene K; Bielicki J; Pfister M; Puchkov M; Huwyler J
Children (Basel); 2021 Mar; 8(3):. PubMed ID: 33807822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
